A lawsuit filed in California federal court by relatives of Dainis Lauris allege he died after suffering blockage in specific areas of the body from atherosclerosis.
No. Families have already filed lawsuits for injury or death related to Tasigna atherosclerosis. Our attorneys believe that filing Tasigna lawsuits against Novartis is the only method to recover compensation and maintain the drugmaker responsible.
(Case No. No. 16-393) The reason for the rising number of Tasigna lawsuit.
InBriefBRIEF–Tasigna approved for pediatric CML in Europe20-11-2017 ArticleCutting cancer medication price ‘makes Colombia leader’ in cost control22-12-2016 ArticleBosulif better than competitor as first-line treatment in rare leukemia, study finds06-12-2016 ArticleSolid 3rd-quarter results from Novartis, despite Gleevec patent expiry25-10-2016 ArticleTeva and Apotex debut generic Gleevec drugs from the USA06-08-2016 ArticleOver 50% of eligible Ph+ CML patients maintain TFR after quitting Tasigna05-06-2016 ArticleIndia’s Sun Pharma launches generic version of Novartis\’ Gleevec in the USA02-02-2016.
It is alleged that Novaritis was aware because 2011, yet no warning was ever given in the United States to patients or doctors.
Using the CML medication Tasigna® can lead to Serious Blood Clots, Limb Amputation, Heart Attack, Stroke or Death.
Tasigna (generic: nilotinib) is a medication that was approved in the U.S. in 2007 for treating Philadelphia chromosome-positive Chronic Myelogenous Leukemia (CML).
} However, exposure to Tasigna had already taken its toll on Lauris’ arteries.
Tasigna is the brand name for nilotinib, a kinase inhibitor which blocks chemical enzymes in cancer cells to be able to prevent division and cell growth.
Tasigna has been linked.
Studies indicate that patients may be endangered by the cancer medication as much as the cancer that it treats.
Atherosclerosis contributes to poor circulation.
Filing a claim and investigating whether you’re eligible is easy.
In March 2016, the family of a man from California who died of atherosclerosis complications after taking Tasigna filed a lawsuit accusing Novartis of failing to warn patients in the U.S. about the threat.
We made this choice based on a lot of examples of prior drug litigation, which sometimes may have resulted in payoutsnonetheless, the amount is a fraction of what their situation could be worth.
If there are lawsuits lodged against the drug’s manufacturers for damages, injuries, and health issues the lawsuits may be combined in an attempt to gather information.
No class action lawsuit was filed so far in the Tasigna litigation.
Chronic Myeloid Leukemia Drug Tasigna Associated with Arteriosclerosis and Wrongful Death.
But despite his change in treatment, Lauris died as a result of complications from his atherosclerosis in March 2014.
“Novartis did not send advisories to the United States public or to United States physicians.
In the future, if a high number of lawsuits are filed, they may be centralized into a federal Multi-District Litigation (MDL) to maximize efficiency.
Drug manufacturers have a legal responsibility and they have an ongoing duty to provide sufficient warnings regarding the risks to patients and physicians.
The people has never been warned of side effects of Tasigna atherosclerosis.
“Novartis’s failure to warn United States doctors and patients of the severe risks of growing atherosclerosis-related conditions associated with Tasigna was intentional, and part of an aggressive marketing strategy to sell Tasigna over competing TKI drugs.
Advanced peripheral arterial disease cause from Tasigna unwanted effects include sores and lesions on the feet that don’t heal. . .
By filing a suit, you may be entitled to a settlement and we can help.
Tasigna Gleevec Bosulif.
We see it as our duty, when families have been harmed by the negligence or greed of a billion dollar pharmaceutical giant.
The billion dollar pharmaceutical company Novartis manufactures and marketed Tasigna.
Fatigue Stomach pain Weakness Abdominal swelling Night sweats Weight loss Fever Bone pain Enlarged spleen.